LinkedIn Profile

Access Revalesio historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:revalesio 3180568 May 31st, 2019 12:00AM Revalesio Corporation 310 20.00 Open Biotechnology May 31st, 2019 11:19AM May 31st, 2019 11:19AM Revalesio Corporation, located in Tacoma, WA, is partnering with leaders in biomedical research around the globe to harness the benefits of fluid modification via turbulent Taylor-Couette-Poiseuille (TCP) flow. Revalesio’s patented application of fluid cavitation within a TCP flow environment has resulted in ground breaking publications in the disciplines of physical chemistry as well as biomedical science. Revalesio is dedicated to commercializing its discoveries through a global drug discovery research and development program that holds significant promise in the area of neurological disorders. Open Clinical Development, Pharmaceutical Manufacturing, Neurological Disorders, Physical Chemistry, Biomedical Science, Scientific R & D Open 1202 East D Street Tacoma Washington US 98421 Revalesio Pharmaceuticals & Biotechnology
private:revalesio 3180568 Feb 17th, 2018 12:00AM Revalesio Corporation 196 18.00 Open Pharmaceuticals Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60. Revalesio Pharmaceuticals & Biotechnology
private:revalesio 3180568 Feb 16th, 2018 12:00AM Revalesio Corporation 196 18.00 Open Pharmaceuticals Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60. Revalesio Pharmaceuticals & Biotechnology
private:revalesio 3180568 Feb 15th, 2018 12:00AM Revalesio Corporation 196 18.00 Open Pharmaceuticals Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60. Revalesio Pharmaceuticals & Biotechnology
private:revalesio 3180568 Feb 14th, 2018 12:00AM Revalesio Corporation 196 18.00 Open Pharmaceuticals Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60. Revalesio Pharmaceuticals & Biotechnology
private:revalesio 3180568 Feb 13th, 2018 12:00AM Revalesio Corporation 196 18.00 Open Pharmaceuticals Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60. Revalesio Pharmaceuticals & Biotechnology
private:revalesio 3180568 Feb 12th, 2018 12:00AM Revalesio Corporation 196 18.00 Open Pharmaceuticals Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60. Revalesio Pharmaceuticals & Biotechnology
private:revalesio 3180568 Feb 11th, 2018 12:00AM Revalesio Corporation 196 18.00 Open Pharmaceuticals Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60. Revalesio Pharmaceuticals & Biotechnology
private:revalesio 3180568 Feb 10th, 2018 12:00AM Revalesio Corporation 196 18.00 Open Pharmaceuticals Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60. Revalesio Pharmaceuticals & Biotechnology
private:revalesio 3180568 Feb 9th, 2018 12:00AM Revalesio Corporation 196 18.00 Open Pharmaceuticals Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Revalesio Corporation is a pioneering clinical stage biomedical company focused on the development of a new class of anti-inflammatory therapeutics. Revalesio initiated the development of its unique charge-stabilized nanostructure (CSN) platform in 2006 and is currently in clinical trials with its lead product candidate RNS60. Revalesio Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.